Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
- Resource Type
- Academic Journal
- Authors
- Crochet G; CHU UCL Namur, Yvoir, Belgium.; Iacoboni G; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain, Barcelona, Spain.; Couturier A; CHU de Rennes, Rennes, France.; Bachy E; Hospices Civils de Lyon, Pierre-Bénite, France.; Iraola-Truchuelo J; Vall d'Hebron University Hospital-Autonomous University of Barcelona, Barcelona, Spain.; Gastinne T; Nantes University hospital, Nantes, France.; Cartron G; CHU Montpellier UMR5535, Montpellier, France.; Fradon T; LYSARC, The Lymphoma Academic Research Organization, Pierre-Bénite, France.; Lesne B; LYSARC, The Lymphoma Academic Research Organization, Pierre-Bénite, France.; Kwon M; Hospital G. Univ. Gregorio Marañon, Institute of Health Research Hospital Gregorio Marañon, Madrid, Spain.; Gounot R; Hôpital Henri Mondor, Créteil, France.; Martínez-Cibrian N; Hospital Clinic, Barcelona, Spain.; Castilla-Llorente C; Gustave Roussy Cancer Campus, Villejuif, France.; Abrisqueta P; Hospital Vall Hebron, Barcelona, Spain.; Guerreiro M; Hospital Universitari i politècnic La Fe, Valencia, Spain.; Sarkozy C; Institut Curie, Hematology department, Saint Cloud, France.; Aspa-Cilleruelo JM; Hospital Universitario Príncipe de Asturias, Universidad de Alcalá, Madrid, Spain.; Camus V; Centre Henri Becquerel, Rouen, France.; Guidez S; CHU de Poitiers.; Chauchet A; CHU, Besancon, France.; Deconinck E; Centre Hospitalier Universitaire Besancon, Besancon, France.; Bouabdallah K; Service d'Hématologie clinique et Thérapie cellulaire, PESSAC, France.; Bosch F; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-1, Barcelona, Spain.; Barba P; Hospital Vall d'Hebron, barcelona, Spain.; Morschhauser F; University of Lille, Lille, France.; Houot R; CHU Rennes, Rennes, France.
- Source
- Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
- Subject
- Language
- English
In this retrospective study, CAR T-cells remained effective in relapsed/refractory LBCL patients after prior exposure to bispecific antibodies (BsAbs) targeting different antigens. These results are relevant to clinical practice, particularly given the increasing use of BsAbs in earlier treatment lines.
(Copyright © 2024 American Society of Hematology.)